Revolution Medicines, Inc. (RVMD)
95.78
-3.51
(-3.54%)
USD |
NASDAQ |
Mar 20, 16:00
95.39
-0.39
(-0.41%)
After-Hours: 20:00
Revolution Medicines Research and Development Expense (Quarterly) : 292.61M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.802B |
| Merck & Co., Inc. | 2.499B |
| AbbVie, Inc. | 2.579B |
| Tango Therapeutics, Inc. | 31.62M |
| Insmed, Inc. | 254.91M |